Literaturverzeichnis

Aho T, Gilling P: Laser therapy for benign prostatic hyperplasia: a review of recent developments. Lippincott Williams & Wilkins, Curr Opin Urol 2003, 13: 39-44

Anidjar M, Mottet N, Teillac P, Le Duc A: A randomized study comparing Holmium YAG laser ablation and transurethral electroresection in the management of benign prostatic hyperplasia. J Urol 1997, 157: 439

Anson K, Nawrocki J, Buckley J: A multicenter randomized prospective study of endoscopic laser ablation versus transurethral resection of the prostate. Urology 1995, 46: 305-310

Arrighi H, Guess H, Metter E: Symptoms and signs of prostatism as risk factors for prostatectomy. Prostate 1990, 16: 253-261

Berger B, Wirtenberger W, Bektik J, Steiner H, Spranger R, Bartsch G, Horninger W: Safer transurethral resection of the prostate: Coagulation intermittent cutting reduces hemostatic complications. J Urol 2004, 171: 289-291

Berges R, Pientka L: Management of the BPH syndrome in Germany: who is treated and how? Eur Urol 1999, 36(suppl 3): 21-27

Berry S, Coffey D, Walsh P, Ewing L: The development of human benign prostatic hyperplasia with age. J Urol 1983, 132: 474-479

Bhatta N, Isaacson K, Bhatta K, Anderson R, Schiff I: Comparative study of different laser systems. Fertil steril 1994, 61: 581-591

Borboroglu G, Kane C, Ward J, Roberts J, Sands J: Immediate and Postoperative Complications of Transurethral Prostatectomy in the 1990s. J Urol 1999, 162: 1307-1310

Böwering R, Hofstetter A, Keiditsch E, Frank F: Irradiation of prostatic carcinoma by neodymium-YAG-laser. In: Optics and photonics applied to medicine. SPIE Proc 1979, 211: 16-20

Bruskewitz R, Larsen E, Madsen P, Dorflinger T: 3 year followup of urinary symptoms after transurethral resesection of the prostate. J Urol 1986, 136: 613-615

Busch C, Daehlin L: Changes in patient characteristics and results for men undergoing transurethral resection of the prostate: 1990 vs. 2000. BJU 2002, 90(2), 91-97

Caine M, Schuger L: The „capsule“ in benign prostatic hypertrophy. U.S. Department of Health and Human Services, NIH Publication No. 87-2881, 1987, p 221

Chapple C, Andersson K, Bono V, et al: α -Blockers: Clinical results. Proc 4th Int Consultation on BPH, Paris, 1997: 610-632

Chapple C: BPH disease management. Eur Urol, 1999, 36(suppl 3): 1-6

Chun S, Razvi H, Denstedt J: Laser prostatectomy with the Holmium:YAG laser. Techniques in Urology 1995, 1: 217-221

Chute C, Panser L, Girman C, Oesterling J, Guess H, Jacobsen S, Lieber M: The prevalence of prostatism: A population-based survey of urinary symptoms.J Urol, 1993, 150: 85-89

Cowles R, Kabalin J, Childs S : A prospective randomized comparison of transurethral resection to visual laser ablation of the prostate for the treatment of the benign prostatic hyperplasia. Urology 1995, 46: 155-160

Curkendall S, Jones J, Dale G: Incidence of medically detected erectile dysfunction and related disease before and after Viagra (sildenafil citrate). Eur Urol 2000, 37 (suppl 2): 81

Das A, Kennett K, Fraundorfer M: Holmium laser resection of the prostate: 2 year followup data. Tech Urol 2001, 7: 252-255

Das A, Kennett K, Sutton T, Fraundorfer M, Gilling P: Histologic effects of Holmium:YAG laser resection versus transurethral resection of the prostate. J Endourol 2000, 14 (5): 459-462

Djavan B, Nickel J, de la Rosette J, Abrams P: The Urologist View of BPH Progression: Results of an International Survey. Eur Urol 2002, 41: 490-494

Doll H, Black N, McPherson K, Flood A, Williams G, Smith J: Mortality, Morbidity and Complicatins following transurethral resection of the prostate for benign prostativ hypertrophy. J Urol 1992, 147: 1566

Donovan J, Frankel S, Nanchahal K et al: Prostatectomy for benigne prostatic hyperplasia. In: Health Care Needs Assessment. Edited by A. Stevens and J. Raftery.  New York: Radcliffe Medical Press, vol. 2, chapt. 1994, 14, 140-201

Donovan J, Peters T, Neal D, Brookes S, Gujral S, Chacko K, Wright M, Kennedy L, Abrams P: A randomized trial comparing transurethral resection of the prostate, laser therapy and conservative treatment of men with symptoms associated with benign prostatic enlargement: The CLasP Study. J Urol 2000, 164: 65-70

Ekman P: Maximum efficacy of finasteride is obtained within 6 months and maintained 6 years: Follow-Up of the Scandinavian Open-Extension Study Group. The Finasterid Scandinavian Study Group. Eur Urol, 1998, 33: 312-317

Flachenecker G, Fastenmeier K, Gminder F: Elektrische Eigenschaften für die TUR. Urologe (B) 1979, 296

Fourcade R, Vallancien G: Morbidity of endoscopic prostatic resection: 3 month prospective study. Practical Urology Club. Prog Urol 2000, 10: 48-52

Fraundorfer MR, Gilling P: Holmium:YAG Laser Enucleation of the Prostate combined with Mechanical Morcellation: Preliminary results. Eur Urol, 1998, 33 , 69-72

Garraway W, Collins G, Lee R: High prevalence of benign prostatic hypertrophy in the community. Lancet 1991, 338: 469-471

Gilling P, Cass C, Cresswell M, Kennett K, Mackay M, Fraundorfer M: The use of the Holmium laser in the treatment of benign prostatic hyperplasia. J Endourol, 1996, 10: 459-461

Gilling P, Fraundorfer M: Holmium laser prostatectomy: technique in evolution. Curr Curr Opin Urol 1998, 8:11-15

Gilling P, Kennett K, Das A, Thompson D, Fraundorfer M: Holmium Laser Enucleation of the Prostate (HoLEP) Combined with Transurethral Tissue Morcellation: An update on the early clinical experience. J Endourol 1998, 12 (5): 457-459

Gilling P, Kennett K, Fraundorfer M: Holmium laser enucleation of the prostate for glands larger than 100g: An endourologic alternative to open prostatectomy. J Endourol 2000, 14:529-531

Gilling P, Mackey M, Cresswell M, Kennett K, Kabalin J, Fraundorfer M: Holmium laser versus transurethral resection of the prostate: a randomized prospective trial with 1-year. J Urol 1999, 162, 1640-1644

Goepel M, Schulze H., Sökeland J: Die benigne Prostatahyperplasie. Dt Ärztebl 2000; 97: 1677-1681

Griffiths C, Murray A, Ramsden P: Accuracy and repeatability of baldder volume measurement by ultrasonic imaging. J Urol, 1986, 136: 808-812

Gujral S, Abrams P, Donovan J, Neal D, Brooks S, Chacko K, Wright M, Timoney A, Peters T: A prospective randomized trial comparing transurethral resection of the prostate and laser therapy in men with chronic urinary retention. The CLasP Study. J Urol 2000, 164 : 59-64

Hagstrom R: Studies on fluid absorption of irrigation fluid during transurethral prostatic resection. J Urol 1955, 73: 852

Hartung R, Barba M: Instrumentelle Therapie der benignen Prostatahyperplasie. Dt Ärztebl 2000, 97: A-989-997

Hartung R, Leyh H, Liapi C, Fastenmeyer K, Barba M: Coagulation intermittent cutting. Improved high-frequency surgery in transurethral prostatectomy. Eur Urol 2001, 39: 676

Hettiarachchi J, Das A: HoLEP: Results of the first hundred patients (abstract). In: Abstracts of the American Urological Association. Orlando 2002. J Urol 2002 167: 1450

Hochreiter W, Hugnnet C, Studer U: Transurethrale Resektion der Prostata mit dem Holmium-Kontaktlaser. Urologe(A) 1999, 38: 156-161

Hofstätter A: Basiswissen Praxis: Prostatakarzinom – Fortschritte in Diagnostik und Therapie. Verlag Urban und Vogel. München 2004

Holtgrewe H, Valk W: Factors influencing the mortality and morbidity of transurethral prostatectomy: A study of 2015 cases. J Urol 1962, 87: 450-459

Horninger W, Unterlechner H, Strasser H, Bartsch G: Transurethral prostatectomy: Mortality and morbidity. Prostate 1996, 28: 195-201

Hubmann R: Geschichte der Medizin: Geschichte der transurethralen Prostataeingriffe Urologe B, 2000, 40: 152-160

Jensen K, Jorgensen J, Mogensen P: Long-term predictive role of urodynamics: An 8-year followup of prostatic surgery for lower urinary tract symptoms. BJU 1996, 78: 213-218

Jensen K: Clinical evaluation of routine urodynamik investigation in prostatism. Neurourol Urodyn 1989, 8: 545-578

Johnson D, Cromeens D, Price R: Use of the Holmium:YAG laser in urology. Lasers Surg Med 1992, 12, 353-363

Kabalin J, Mackey M, Cresswell M, Fraundorfer M, Gilling P : Holmium:YAG Laser resection of the prostate for patients in urinary retention. J Endourol, 1997, 11: 291-293

Kabalin J: Holmium:YAG laser prostatectomy canine feasibility study.  Lasers Surg Med 1996, 18, 221-224

Kaplan S, Garvin D, Gilhooly P, Koppel M, Labasky R., Milsten R, Reddy P, Rosenberg S, Sussman D, White C, Pappas F, WaldstreicherJ: Impact of baseline symptom severity on future risk of benign prostatic hyperplasia-related outcomes and long-term response to finasteride. The Pless Study Group. J Urol 2000, 56 (4): 610-616

Kaplan S, Wassam J, Kirby R: BPH: where are we in 1996? AUA News 1996, 1: 25-27

Keoghane S, Sullivan M, Doll H: Five year data from the Oxford laser prostatectomy trial. BJU 2000, 86: 227-228

Kortt M, Bootman J: The economics of benign prostatic hyperplasia treatment: a literature review. Clin Ther 1996, 18: 1227-1241

Kuntz R, Ahyai S, Lehrich K, Fayad A: Transurethral holmium laser enucleation of the prostate versus transurethral electrocautery resection of the prostate: A randomized prospective trial in 200 patients. J Urol 2004, 172: 1012-1016

Kuntz R, Gilling P, Fraundorfer M: Transurethrale holmiumlaser resektion der Prostata (HoLRP) und Holmiumlaser Enukleation der Prostata. Akt. Urol. 1998, 29: 139-148

Kuntz R, Lehrich K: Transurethral holmium-laser-enucleation (HoLEP) of large prostate glands. J Endourol 2002, 13: A99

Kuntz R, Lehrich K: Transurethral holmium-laser-enucleation versus transvesical open enucleation for prostate adenoma greater than 100 gm.: A randomized prospective trial of 120 patients. J Urol 2002, 168: 1465-1469

Kuo R, Paterson R, Siqueira T: HoLEP: Morbidity in a series of 193 patients (abstract). In: Abstracts of the American Urological Association. Orlando, 2002. J Urol 2002, 167: 1164

Larizgoita I, Pons J: A systematic review of the clinical efficacy and effectiveness of the holmium:YAG laser in urology. BJU International 1999, 84, 1-9

Larner T, Agarwal D, Costello A: Day case holmium enucleation of the prostate for gland volumes of < 60 ml: early experience. BJU 2003, 91: 61-64

Larsen E, Bruskewitz R: Urodynamik evaluation of male outflow obstruction; in Krane R, Siroky B (eds):  Clinical Neurourology, 1991: 427-443

Le Duc, A, Gilling, P: Holmium laser resection of the prostate. Eur Urol 1999, 35: 155-160

Levin R, Monson F, Haugaard N, et al: Genetic and cellular characteristics of bladder outlet obstruction. Urol Clin North Am 1995; 22:263-283

Mackey M, Chilton C, Gilling P, Fraundorfer M, Cresswell M: The results of holmium laser resection of the prostate. BJU 1998, 81: 518-519

Madersbacher S, Klingler H, Schatzl G, Stulning T, Schmidbauer C, Marberger M: Age related changes in patients with benigne prostatic hyperplasia. J Urol, 1996, 156: 1662-1667

Madersbacher S, Marberger M : Is transurethral resection of the prostate still justified? BJU 1999, 83: 227-237

Madsen P: Irrigation fluids and their adsorption and excreting during transurethral resection of the prostate. Thesis, University of Copenhagen. Denmark 1976

Mauermayer W: Allgemeine Resektionstechnik. In: Transurethrale Operationen. Mauermeyer W (Hrsg) Berlin: Springer Verlag 1981

McAllister W, Karim O, Plail R, Samra D, Steggall M, Yang Q, Fowler C: Transurethral electrovaporization of the prostate: Is it any better than conventional transurethral resection of the prostate? J Urol 91, 211-214

McConnell E: Discovering a post-TURP complication. Nursing 1989, 19: 96-98

McNeal J: Origin and evolution of benign prostatic enlargement. Invest Urol 1978; 15:340

McNicholas, T: Management of symptomatic BPH in the UK: who is treated and how?. Eur Urol, 1999, 36: 33

Mebust W, Holtgrewe H, Cockett A, et al: Transurethral prostatectomy: Immediate and postoperative complications. A cooperative study of thirteen participating institutions evaluating 3,885 patients.  J Urol 1989;141: 243–247.

Mebust W, Holtgrewe H, Cockett A, Peters P, Writing Committee. Transurethral prostatectomy: Immediate postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol 1989, 141: 243-247

Melchior J, Valk W, Forret J, Mebust W: Transurethral prostatectomy: Computerized analysis of 2223 consecutive cases. J Urol 1974, 112: 624

Moody J, Lingeman J: Holmium laser enucleation for prostate adenoma greater than 100gm.: Comparison to open prostatectomy. J Urol 2001, 165: 459-462

Narayan P, Tewari A: Overview of alpha-blocker therapy for benign prostatic hyperplasia: Urology 1998, 51: 38-45

Naspro R, Freschi M, Salonia A, Guazzoni G, Di Girolamo V, Scattoni R, Rigatti P, Montorsi F: Holmium laser enucleation versus transurethal resection of the prostate. Are histological findings comparable? J Urol 2004, 171 (3): 1203-1206

Pommer S, Dobrowolski Z: The therapy of benign prostatic hyperplasia using less-invasive procedures: the current situation. BJU International 2002, 89, 773-775

Puppo P, Degrandchamps F, Castro-Díaz D, Madersbacher S: Alternatives to TURP: outcome analysis and indication tuning. Eur Urology 2002, 42: 1-10

Roos N, Wennberg J, Malenka D, Fischer E, McPherson K, Andersen T, Cohen M, Ramsey E: Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. Special article. N Engl J Med 1989, 320: 1120-1124

Rosen R, Altwein J, Boyle P, Kirby R, Lukasc B, Meuleman E: Lower urinary tract symptoms and male sexual dysfunction: multinational survey of the aging male (MSAM-7). Eur Urol, 2003, 44: 637

Shah J, Whitfield H: Urology in perspective. BJU 2003: 737-742

Smith R: Complications of Transurethral Surgery. In: Complications of urologic surgery. Smith and Ehrlich (Hrsg). W.B. Saunders (1990) 355-376

Spindel M, Moslem A, Bhatia K et al: Comparison of holmium and flash-lamp pumped-dye lasers for use in lithotripsy of biliary calculi. Lasers Surg Med 1992, 12, 482-489

Svanholm H, Starklind H, Barlebo H, Olsen S: Histological evaluation of prostatic cancer. (II): reproducibility of a histological grading system. APMIS 1990, 98: 229-236

Tan A, Gilling P, Kennett K, Frampton C, Westenberg A, Fraundorfer M: A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams). J Urol 2003, 170: 1270-1274

Tazaki H, Aynchchi S, Samadi A, Tortorelis D, Konno S, Choudoury M, Eshghi M: Holmium laser use in critically ill patients. BJU 2002, 90 (2), 91-97

Uchida T, Ohori M, Soh S, Sato T, Iwamura M, Ao T, Koshiba K: Factors influencing morbidity in patients undergoing transurethral resection of the prostate. Elsevier Sience Inc.,1999, Urology 53 (1), 98-104

van Melick H, van Venrooij G, Eckhardt M, Boon T: A randomized controlled trial comparing transurethral resection of the prostate, contact laser prostatectomy and electrovaporisation in man with benign prostatic hyperplasia: Analysis of subjective changes, morbidity and mortality. J Urol 2003 169: 1411-1416

Walsh PC: Benign prostatic Hyperplasia. In Walsh P, Gittes R, Perlmutter A, Stamey T : Campell`s Urology, 5th ed. Saunders, Philadelphia 1986, p 1248

Westenberg A, Gilling P, Kennett K, Frampton C, Fraundorfer M: Holmium laser resection of the prostate versus transurethral resection of the prostate: Results of a randomized trial with 4-year minimum long-term followup. J Urol 2004, 172: 616-619

Wheelahan J, Scott N, Cartmill R, Marshall V, Morton R, Nacey J, Maddern G: Minimal invasive laser techniques for prostatectomy: a systematic review. BJU 2000, 86: 805-815

Wittekind C, Klimpfinger M, Sobin L: TNM-Atlas. Illustrierter Leitfaden zur TNM-Klassifikation maligner Tumoren. Springer Verlag 2005, 5. Auflage, 383 Seiten